These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9818065)

  • 1. Some hope from marine natural products.
    D'Incalci M
    Ann Oncol; 1998 Sep; 9(9):937-8. PubMed ID: 9818065
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in the development and acquisition of anticancer agents from marine sources.
    Amador ML; Jimeno J; Paz-Ares L; Cortes-Funes H; Hidalgo M
    Ann Oncol; 2003 Nov; 14(11):1607-15. PubMed ID: 14581267
    [No Abstract]   [Full Text] [Related]  

  • 3. Sea squirt assaults sarcomas.
    Burton A
    Lancet Oncol; 2002 Nov; 3(11):648. PubMed ID: 12424055
    [No Abstract]   [Full Text] [Related]  

  • 4. Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics.
    Le VH; Inai M; Williams RM; Kan T
    Nat Prod Rep; 2015 Feb; 32(2):328-47. PubMed ID: 25273374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New drugs from the sea.
    D'Incalci M; Simone M; Tavecchio M; Damia G; Garbi A; Erba E
    J Chemother; 2004 Nov; 16 Suppl 4():86-9. PubMed ID: 15688619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action.
    Erba E; Bergamaschi D; Bassano L; Damia G; Ronzoni S; Faircloth GT; D'Incalci M
    Eur J Cancer; 2001 Jan; 37(1):97-105. PubMed ID: 11165136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ecteinascidin 743].
    Lansiaux A; Bailly C
    Bull Cancer; 1999 Feb; 86(2):139-41. PubMed ID: 10094523
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development of marine-derived anti-cancer compounds].
    Taguchi T
    Gan To Kagaku Ryoho; 2003 May; 30(5):579-88. PubMed ID: 12795086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical and clinical results with the natural marine product ET-743.
    D'Incalci M; Jimeno J
    Expert Opin Investig Drugs; 2003 Nov; 12(11):1843-53. PubMed ID: 14585059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer squirt.
    Bonetta L
    Nat Med; 2001 Aug; 7(8):891. PubMed ID: 11479616
    [No Abstract]   [Full Text] [Related]  

  • 11. Marine natural products as anticancer drugs.
    Simmons TL; Andrianasolo E; McPhail K; Flatt P; Gerwick WH
    Mol Cancer Ther; 2005 Feb; 4(2):333-42. PubMed ID: 15713904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecteinascidin 743: a novel anticancer drug with a unique mechanism of action.
    Aune GJ; Furuta T; Pommier Y
    Anticancer Drugs; 2002 Jul; 13(6):545-55. PubMed ID: 12172500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of antimitotic products from marine organisms that disorganise the microtubule network: ecteinascidin 743, isohomohalichondrin-B and LL-15.
    García-Rocha M; García-Gravalos MD; Avila J
    Br J Cancer; 1996 Apr; 73(8):875-83. PubMed ID: 8611420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical armamentarium of marine-derived anti-cancer compounds.
    Jimeno JM
    Anticancer Drugs; 2002 May; 13 Suppl 1():S15-9. PubMed ID: 12173490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important classes of bioactive alkaloids from marine ascidians: structures, isolation and bioactivity.
    Menna M
    Curr Top Med Chem; 2014; 14(2):207-23. PubMed ID: 24359200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766.
    Drugs R D; 2006; 7(5):317-28. PubMed ID: 16922593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients.
    Izbicka E; Lawrence R; Raymond E; Eckhardt G; Faircloth G; Jimeno J; Clark G; Von Hoff DD
    Ann Oncol; 1998 Sep; 9(9):981-7. PubMed ID: 9818072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of melanoma cells.
    Biroccio A; Gabellini C; Amodei S; Benassi B; Del Bufalo D; Elli R; Antonelli A; D'Incalci M; Zupi G
    Mol Pharmacol; 2003 Mar; 63(3):632-8. PubMed ID: 12606771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair.
    Takebayashi Y; Pourquier P; Zimonjic DB; Nakayama K; Emmert S; Ueda T; Urasaki Y; Kanzaki A; Akiyama SI; Popescu N; Kraemer KH; Pommier Y
    Nat Med; 2001 Aug; 7(8):961-6. PubMed ID: 11479630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orphan anticancer drug rejected.
    Burton A
    Lancet Oncol; 2003 Sep; 4(9):524. PubMed ID: 12965283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.